Seelos Therapeutics Inc
SEEL
Company Profile
Business description
Seelos Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on developing products that address unmet needs in Central Nervous System (CNS) disorders and other rare disorders. Its product pipeline includes SLS-002, SLS-005, SLS-004, SLS-007, and SLS-009.
Contact
300 Park Avenue
2nd Floor
New York NY 10022
USAT: +1 646 293-2100
E: info@seelostx.com
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2024
Employees
8
Stocks News & Analysis
stocks
Morningstar recommends investors reject takeover offer on A-REIT
The bid barely exceeds our fair value and is a 10% discount to net tangible asset value.
stocks
The lessons behind the best performing stock over the last 80 years
4 factors that led to the incredible returns of Philip Morris.
stocks
I ignored Buffett's advice and it cost me
Warren Buffett has three main criteria for buying a business but most investors only focus on two of them.
Morningstar Investment Ideas
Stocks
ETFs
- Australian ETFs
- Active Australian Equity ETFs
- Passive Australian Equity ETFs
- Emerging Market Equity ETFs
- Sustainable ETFs
- Active Global Equity ETFs
- Passive Global Equity ETFs
- Active Australian Fixed Interest ETFs
- Passive Australian Fixed Interest ETFs
- Active Australian Listed Property ETFs
- Passive Australian Listed Property ETFs
- Active Global Fixed Interest ETFs
- Passive Global Fixed Interest ETFs
- Active Global Infrastructure ETFs
- Passive Global Infrastructure ETFs
- Active Global Property ETFs
- Passive Global Property ETFs
Funds
- Active Australian Equity Funds
- Passive Australian Equity Funds
- Active Global Equity Funds
- Passive Global Equity Funds
- Sustainable Funds
- Emerging Market Equity Funds
- Passive Australian Listed Property Funds
- Active Australian Listed Property Funds
- Passive Global Infrastructure Funds
- Active Global Infrastructure Funds
- Active Global Property Funds
- Passive Global Property Funds
- Active Australian Fixed Interest Funds
- Passive Australian Fixed Interest Funds
- Active Global Fixed Interest Funds
- Passive Global Fixed Interest Funds
Markets
Index
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| All Ordinaries | 8,217.00 | 25.10 | 0.31% |
| CAC 40 | 7,407.55 | 17.71 | -0.24% |
| DAX 40 | 18,265.92 | 177.64 | -0.96% |
| Dow JONES (US) | 40,654.01 | 175.58 | -0.43% |
| FTSE 100 | 8,205.98 | 64.86 | -0.78% |
| HKSE | 17,234.09 | 37.13 | 0.22% |
| NASDAQ | 16,940.32 | 55.72 | 0.33% |
| Nikkei 225 | 36,159.16 | 56.59 | -0.16% |
| NZX 50 Index | 12,632.82 | 11.20 | 0.09% |
| S&P 500 | 5,476.08 | 5.03 | 0.09% |
| S&P/ASX 200 | 8,011.90 | 23.80 | 0.30% |
| SSE Composite Index | 2,744.19 | 7.70 | 0.28% |
Market Movers
Name
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| Bowen Coking Coal Ltd BCB | 0.01 | 0.00 | -22.22% |
| Red 5 Ltd RED | 0.29 | 0.01 | -1.72% |
| Telstra Group Ltd TLS | 3.95 | 0.03 | 0.77% |
| Pilbara Minerals Ltd PLS | 2.36 | 0.05 | -2.07% |
| GPT Group GPT | 5.09 | 0.01 | -0.20% |
| Steadfast Group Ltd SDF | 5.32 | 0.64 | -10.74% |
| Appen Ltd APX | 1.34 | 0.10 | 7.63% |
| South32 Ltd S32 | 2.99 | 0.02 | 0.67% |
| Core Lithium Ltd CXO | 0.09 | 0.00 | 4.76% |
| Scentre Group SCG | 3.54 | 0.01 | -0.28% |